Special Issue "Medicinal Plants and Their Active Ingredients in Cancer"
Deadline for manuscript submissions: 30 April 2021.
Interests: pharmacology; natural products; neurotransmission; behavioral pharmacology; experimental pharmacology; preclinical pharmacology; CB1 receptor; PPARs; cannabinoids; endocannabinoids; CB2 receptor
Special Issues and Collections in MDPI journals
Special Issue in Molecules: Role of PPAR Receptors in Human Health and Disease
Special Issue in Molecules: Plant Extracts: Biological and Pharmacological Activity
Special Issue in Molecules: Research on the Cannabinoid Receptors Pharmacology
Special Issue in International Journal of Molecular Sciences: Role of Nutraceuticals in Metabolic and Gastrointestinal Disorders
Special Issue in Biomolecules: Pharmacology of Medicinal Plants
Special Issue in International Journal of Molecular Sciences: The Role of Microbiota in Wellness and Target Therapy: Molecular and Mechanistic Insights
Special Issue in Biomedicines: Natural Medicine in Therapy
Special Issue in International Journal of Molecular Sciences: Biological Properties of Medicinal Plants
Special Issue in Molecules: Plant Extracts: Biological and Pharmacological Activity—the Second Edition
Interests: pharmacology; natural products; cancer; neurotransmission; experimental pharmacology; preclinical pharmacology; CB1 receptor; PPARs; cannabinoids; endocannabinoids; CB2 receptor
Cancer is a multifactorial disease driven by the accumulation of genetic mutations and epigenetic changes that lead to cell malignancy, and it has several distinctive signs, such as anti-apoptosis, proliferation, resistance to cell death, angiogenesis, invasion, migration, and metastasis. Globally, cancer remains a major problem in human health. As such, it is very important to prevent or treat several cancers.
Medicinal plants and their active ingredients play an important role in the discovery of new drugs and innovative mechanisms of action.
Medicinal plants contain multiple compounds which, individually or together, are responsible for the biological effects of these natural products. Although many natural products of plant origin have already been isolated and characterized, the molecular mechanisms underlying their therapeutic effects remain unexplored.
This Special Issue aims to contribute with original articles and reviews (e.g., systematic reviews) to the identification of chemopreventive agents that delay or block the carcinogenesis of human tumors. To ensure the quality of the articles in the special issue, the mechanism of action of the active compounds in the extracts and in vivo study should be included.
Prof. Dr. Raffaele Capasso
Dr. Barbara Romano
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medicinal plants
- secondary metabolites
- microbiota and cancer
- pharmacological interactions
- natural products
- preclinical and clinical trials in cancer
- nutraceuticals anc cancer
- molecular mechanisms